PTSM: Pharmaceutical Technology Sourcing and Management, Apr 2, 2014 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

PTSM: Pharmaceutical Technology Sourcing and Management, Apr 2, 2014
Outsourcing
How Will CMO Ownership Changes Impact Market?
By Jim Miller
Changes in company ownership shake up the CMO industry.
Western CMOs Rise Again, Face New Challenges
By Andreas Weiler
Increased competition from CMOs in Asia means that Western CMOs need to understand fundamental changes in the market.
Drug Delivery
Drug Delivery Technologies Provide Growth Opportunities for Biopharmaceuticals
By Cynthia Challener, PhD
Advanced drug delivery technologies can increase efficacy and safety, extend patent lives, and provide competitive differentiation for biopharmaceuticals.
API Synthesis & Manufacturing
Synthetic Biology Stirs Interest in Greener, More Efficient Processes
By Cynthia Challener, PhD
The commercial availability of an increasing diversity of enzymes has led to the growing use of biocatalysts for API synthesis.
Business
Pharma Industry Corruption in China Under Scrutiny
By Jane Wan
China's regulatory and compliance environment is set to change as the government declares a crackdown on bribery scandals.
CSR and Sustainability Forum
PhRMA Launches National Campaign to Increase Diversity in Clinical Trials
By Melanie Sena
The I'm In campaign is designed to increase participation by diverse patient populations for clinical trials.
Contract Services
Covance Expands Global Biologics Capabilities
By Melanie Sena
Covance adds workspace and scientists to biologics team in Indianapolis facility.
Vetter Implements New Serialization Services
By Melanie Sena
Vetter launches new serialization process to support track-and-trace efforts.
Catalent Increases Investment in Redwood Bioscience
By Melanie Sena
Catalent increases its minority investment in Redwood Bioscience for engineering ADCs.
AmerisourceBergen Acquires Minority Interest in Profarma
By Melanie Sena
AmerisourceBergen to establish a joint venture for specialty distribution with Profarma.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
Click here